NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|28574153|ref|NP_788042|]
View 

Ance-2 [Drosophila melanogaster]

Protein Classification

M2 family metallopeptidase( domain architecture ID 10157887)

M2 family metallopeptidase similar to angiotensin converting enzyme (ACE), a zinc-dependent dipeptidyl carboxypeptidase

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M2_ACE cd06461
Peptidase family M2, angiotensin converting enzyme (ACE); Peptidase family M2 angiotensin ...
26-601 0e+00

Peptidase family M2, angiotensin converting enzyme (ACE); Peptidase family M2 angiotensin converting enzyme (ACE, EC 3.4.15.1) is a membrane-bound, zinc-dependent dipeptidase that catalyzes the conversion of the decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II, by removing two C-terminal amino acids. There are two forms of the enzyme in humans, the ubiquitous somatic ACE and the sperm-specific germinal ACE, both encoded by the same gene through transcription from alternative promoters. Somatic ACE has two tandem active sites with distinct catalytic properties, whereas germinal ACE, the function of which is largely unknown, has just a single active site. Recently, an ACE homolog, ACE2, has been identified in humans that differs from ACE; it preferentially removes carboxy-terminal hydrophobic or basic amino acids and appears to be important in cardiac function. ACE homologs (also known as members of the M2 gluzincin family) have been found in a wide variety of species, including those that neither have a cardiovascular system nor synthesize angiotensin. ACE is well-known as a key part of the renin-angiotensin system that regulates blood pressure and ACE inhibitors are important for the treatment of hypertension.


:

Pssm-ID: 341055  Cd Length: 563  Bit Score: 538.73  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153  26 FLNETNQQLAVIYDQAVLAQLLNELRGpNDLVALLEIEVtDDKLVKYVRTLTTRKAKFKRLGLGDSRQRRLLDKIPQLGY 105
Cdd:cd06461   1 FLEEYNEEASKLYNRSAEAQWNYETNI-TDENLQALLEA-SLELSKFVKEAAENAKKFDWQDFLDPDLKRQLKLLSRLGV 78
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 106 EALSGRDLKLVYALASSMSDNYHNVKLCAYKQPGNCTLRLIPEVQSIVQGSRDLDEIEYYWFEWRSRTGLATRSQFVDFM 185
Cdd:cd06461  79 AALDEEDLEELNELLSEMEKIYSTAKVCPYDNPSCCCLLLEPDLTNILATSRDYDELLYAWKGWRDAVGKKMRPLYEEYV 158
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 186 DLYKKTAQLNGYPRAEDYWFRSLELkgQETMNLLDRIMHGLRPLFLQFHAHVRGSLRKMHGEHLVPRNRPYPQHLaevfI 265
Cdd:cd06461 159 ELSNEAARLNGFADAGEYWRSSYEM--DEFEEELERLWEQIKPLYEQLHAYVRRKLRKKYGDDVIPKDGPIPAHL----L 232
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 266 GNAFRRvEAEWYVDL--PSPEIGLANITQELHRRGLsTTQRVFWNVAEYFRALGFPQLENSLWTYAQKVSSDD-DDRCWH 342
Cdd:cd06461 233 GNMWAQ-SWSNIYDLvvPYPDKPSLDVTPELKKQNY-TAKKMFKLAEEFFTSLGLPPLPKSFWEKSMFEKPPDrEVVCHA 310
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 343 KAWRYYALPRTNFTYCPLNDEERFFNMFEAQSDLQYYRAASIQPTLLQEEPFPNFSDAIGKCFSMAASSPRFLRKLGMLR 422
Cdd:cd06461 311 SAWDFYNGDDFRIKMCTEVTMEDFLTVHHEMGHIQYYMAYKDQPVLFREGANPGFHEAIGDTIALSVSTPKHLKRLGLLD 390
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 423 DNKWKElPARLNRLYIQGLRVVFLLPVFYVLDRYRVEVLAGHIKADD-NEAYWRLTELYTGAAAPTKRTNEQFDVPAKLL 501
Cdd:cd06461 391 DNVDDE-EADINFLLKQALDKIAFLPFGYLLDKWRWDVFSGEIPPDEyNEAWWELREKYQGIVPPVPRSEEDFDPGAKYH 469
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 502 MEVDDQYASNFLSIVLQFQLLKHFCTITGQfemgnpRKPLDMCDLSDQRGIGEILKRAMSLGSSVHYREVLKVLLGEPEI 581
Cdd:cd06461 470 IPANTPYIRYFLSTILQFQFHKALCKAAGH------TGPLHKCDIYGSKEAGKKLKKMLSLGSSKPWPDALEELTGEREL 543
                       570       580
                ....*....|....*....|
gi 28574153 582 SIDGLLTYFQPLQDWLQHQN 601
Cdd:cd06461 544 DASPLLEYFQPLYDWLKEEN 563
 
Name Accession Description Interval E-value
M2_ACE cd06461
Peptidase family M2, angiotensin converting enzyme (ACE); Peptidase family M2 angiotensin ...
26-601 0e+00

Peptidase family M2, angiotensin converting enzyme (ACE); Peptidase family M2 angiotensin converting enzyme (ACE, EC 3.4.15.1) is a membrane-bound, zinc-dependent dipeptidase that catalyzes the conversion of the decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II, by removing two C-terminal amino acids. There are two forms of the enzyme in humans, the ubiquitous somatic ACE and the sperm-specific germinal ACE, both encoded by the same gene through transcription from alternative promoters. Somatic ACE has two tandem active sites with distinct catalytic properties, whereas germinal ACE, the function of which is largely unknown, has just a single active site. Recently, an ACE homolog, ACE2, has been identified in humans that differs from ACE; it preferentially removes carboxy-terminal hydrophobic or basic amino acids and appears to be important in cardiac function. ACE homologs (also known as members of the M2 gluzincin family) have been found in a wide variety of species, including those that neither have a cardiovascular system nor synthesize angiotensin. ACE is well-known as a key part of the renin-angiotensin system that regulates blood pressure and ACE inhibitors are important for the treatment of hypertension.


Pssm-ID: 341055  Cd Length: 563  Bit Score: 538.73  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153  26 FLNETNQQLAVIYDQAVLAQLLNELRGpNDLVALLEIEVtDDKLVKYVRTLTTRKAKFKRLGLGDSRQRRLLDKIPQLGY 105
Cdd:cd06461   1 FLEEYNEEASKLYNRSAEAQWNYETNI-TDENLQALLEA-SLELSKFVKEAAENAKKFDWQDFLDPDLKRQLKLLSRLGV 78
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 106 EALSGRDLKLVYALASSMSDNYHNVKLCAYKQPGNCTLRLIPEVQSIVQGSRDLDEIEYYWFEWRSRTGLATRSQFVDFM 185
Cdd:cd06461  79 AALDEEDLEELNELLSEMEKIYSTAKVCPYDNPSCCCLLLEPDLTNILATSRDYDELLYAWKGWRDAVGKKMRPLYEEYV 158
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 186 DLYKKTAQLNGYPRAEDYWFRSLELkgQETMNLLDRIMHGLRPLFLQFHAHVRGSLRKMHGEHLVPRNRPYPQHLaevfI 265
Cdd:cd06461 159 ELSNEAARLNGFADAGEYWRSSYEM--DEFEEELERLWEQIKPLYEQLHAYVRRKLRKKYGDDVIPKDGPIPAHL----L 232
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 266 GNAFRRvEAEWYVDL--PSPEIGLANITQELHRRGLsTTQRVFWNVAEYFRALGFPQLENSLWTYAQKVSSDD-DDRCWH 342
Cdd:cd06461 233 GNMWAQ-SWSNIYDLvvPYPDKPSLDVTPELKKQNY-TAKKMFKLAEEFFTSLGLPPLPKSFWEKSMFEKPPDrEVVCHA 310
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 343 KAWRYYALPRTNFTYCPLNDEERFFNMFEAQSDLQYYRAASIQPTLLQEEPFPNFSDAIGKCFSMAASSPRFLRKLGMLR 422
Cdd:cd06461 311 SAWDFYNGDDFRIKMCTEVTMEDFLTVHHEMGHIQYYMAYKDQPVLFREGANPGFHEAIGDTIALSVSTPKHLKRLGLLD 390
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 423 DNKWKElPARLNRLYIQGLRVVFLLPVFYVLDRYRVEVLAGHIKADD-NEAYWRLTELYTGAAAPTKRTNEQFDVPAKLL 501
Cdd:cd06461 391 DNVDDE-EADINFLLKQALDKIAFLPFGYLLDKWRWDVFSGEIPPDEyNEAWWELREKYQGIVPPVPRSEEDFDPGAKYH 469
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 502 MEVDDQYASNFLSIVLQFQLLKHFCTITGQfemgnpRKPLDMCDLSDQRGIGEILKRAMSLGSSVHYREVLKVLLGEPEI 581
Cdd:cd06461 470 IPANTPYIRYFLSTILQFQFHKALCKAAGH------TGPLHKCDIYGSKEAGKKLKKMLSLGSSKPWPDALEELTGEREL 543
                       570       580
                ....*....|....*....|
gi 28574153 582 SIDGLLTYFQPLQDWLQHQN 601
Cdd:cd06461 544 DASPLLEYFQPLYDWLKEEN 563
Peptidase_M2 pfam01401
Angiotensin-converting enzyme; Members of this family are dipeptidyl carboxydipeptidases ...
25-610 9.75e-99

Angiotensin-converting enzyme; Members of this family are dipeptidyl carboxydipeptidases (cleave carboxyl dipeptides) and most notably convert angiotensin I to angiotensin II. Many members of this family contain a tandem duplication of the 600 amino acid peptidase domain, both of these are catalytically active. Most members are secreted membrane bound ectoenzymes.


Pssm-ID: 460196  Cd Length: 581  Bit Score: 312.59  E-value: 9.75e-99
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153    25 RFLNETNQQLAVIYDQAVLAQLLNE--LRGPNDLvALLEIEVtddKLVKYVRTLTTRKAKFKRLGLGDSRQRRLLDKIPQ 102
Cdd:pfam01401   9 EFLEEYNREAEKVLNESTEASWNYNtnITDENAQ-KMLEASL---ELAAFTKETAQEAKQFDWSNFQDPDLKRQFKKLSV 84
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153   103 LGYEALSGRDLKLVYALASSMSDNYHNVKLCAYKQPGNCtLRLIPEVQSIVQGSRDLDEIEYYWFEWRSRTGLATRSQFV 182
Cdd:pfam01401  85 LGTAALPEDKLEELNTILSEMESIYSKAKVCLYDDPGPC-LSLEPDLTEIMATSRDYDELLWAWEGWRDAVGKPLRPLYE 163
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153   183 DFMDLYKKTAQLNGYPRAEDYWFRSLElkgQET-MNLLDRIMHGLRPLFLQFHAHVRGSLRKMHGEHLVPRNRPYPQHLa 261
Cdd:pfam01401 164 RYVELSNEAAKLNGYADTGAYWRSWYE---SDTfEEDLERLFQQLKPLYLQLHAYVRRKLREKYGPDVISLTGPIPAHL- 239
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153   262 evfIGNAFRRveaEW---YvDL--PSPEIGLANITQELHRRGLsTTQRVFWNVAEYFRALGFPQLENSLWTYAQ--KVSS 334
Cdd:pfam01401 240 ---LGNMWAQ---SWsniY-DLvvPFPDKPNIDVTDAMVAQGY-TAKKMFEEAEEFFTSLGLLPMPPEFWDKSMleKPTD 311
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153   335 DDDDRCWHKAWRYYAlpRTNF--TYCPLNDEERFFNMFEAQSDLQYYRAASIQPTLLQEEPFPNFSDAIGKCFSMAASSP 412
Cdd:pfam01401 312 GREVVCHASAWDFYN--GKDFriKMCTEVTMEDFFTVHHEMGHIQYYLQYKDQPVLFREGANPGFHEAVGDVLALSVSTP 389
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153   413 RFLRKLGMLrDNKWKELPARLNRLYIQGLRVVFLLPVFYVLDRYRVEVLAGHIKADD-NEAYWRLTELYTGAAAPTKRTN 491
Cdd:pfam01401 390 KHLKSIGLL-DDVVEDEESDINFLLKQALDKIAFLPFGYLIDKWRWGVFSGEIPPEDyNKRWWELRLKYQGICPPVPRTE 468
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153   492 EQFDVPAKLLMEVDDQYASNFLSIVLQFQLLKHFCTITGQFemgnprKPLDMCDLSDQRGIGEILKRAMSLGSSVHYREV 571
Cdd:pfam01401 469 SDFDPGAKYHVPANVPYIRYFVSFILQFQFHKALCQAAGHT------GPLHKCDIYGSKEAGAKLKEMLKLGSSKPWPEA 542
                         570       580       590
                  ....*....|....*....|....*....|....*....
gi 28574153   572 LKVLLGEPEISIDGLLTYFQPLQDWLQHQNQENNLEVGW 610
Cdd:pfam01401 543 LEAITGQRKMDASALLEYFEPLIDWLKEQNERNGEIVGW 581
 
Name Accession Description Interval E-value
M2_ACE cd06461
Peptidase family M2, angiotensin converting enzyme (ACE); Peptidase family M2 angiotensin ...
26-601 0e+00

Peptidase family M2, angiotensin converting enzyme (ACE); Peptidase family M2 angiotensin converting enzyme (ACE, EC 3.4.15.1) is a membrane-bound, zinc-dependent dipeptidase that catalyzes the conversion of the decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II, by removing two C-terminal amino acids. There are two forms of the enzyme in humans, the ubiquitous somatic ACE and the sperm-specific germinal ACE, both encoded by the same gene through transcription from alternative promoters. Somatic ACE has two tandem active sites with distinct catalytic properties, whereas germinal ACE, the function of which is largely unknown, has just a single active site. Recently, an ACE homolog, ACE2, has been identified in humans that differs from ACE; it preferentially removes carboxy-terminal hydrophobic or basic amino acids and appears to be important in cardiac function. ACE homologs (also known as members of the M2 gluzincin family) have been found in a wide variety of species, including those that neither have a cardiovascular system nor synthesize angiotensin. ACE is well-known as a key part of the renin-angiotensin system that regulates blood pressure and ACE inhibitors are important for the treatment of hypertension.


Pssm-ID: 341055  Cd Length: 563  Bit Score: 538.73  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153  26 FLNETNQQLAVIYDQAVLAQLLNELRGpNDLVALLEIEVtDDKLVKYVRTLTTRKAKFKRLGLGDSRQRRLLDKIPQLGY 105
Cdd:cd06461   1 FLEEYNEEASKLYNRSAEAQWNYETNI-TDENLQALLEA-SLELSKFVKEAAENAKKFDWQDFLDPDLKRQLKLLSRLGV 78
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 106 EALSGRDLKLVYALASSMSDNYHNVKLCAYKQPGNCTLRLIPEVQSIVQGSRDLDEIEYYWFEWRSRTGLATRSQFVDFM 185
Cdd:cd06461  79 AALDEEDLEELNELLSEMEKIYSTAKVCPYDNPSCCCLLLEPDLTNILATSRDYDELLYAWKGWRDAVGKKMRPLYEEYV 158
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 186 DLYKKTAQLNGYPRAEDYWFRSLELkgQETMNLLDRIMHGLRPLFLQFHAHVRGSLRKMHGEHLVPRNRPYPQHLaevfI 265
Cdd:cd06461 159 ELSNEAARLNGFADAGEYWRSSYEM--DEFEEELERLWEQIKPLYEQLHAYVRRKLRKKYGDDVIPKDGPIPAHL----L 232
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 266 GNAFRRvEAEWYVDL--PSPEIGLANITQELHRRGLsTTQRVFWNVAEYFRALGFPQLENSLWTYAQKVSSDD-DDRCWH 342
Cdd:cd06461 233 GNMWAQ-SWSNIYDLvvPYPDKPSLDVTPELKKQNY-TAKKMFKLAEEFFTSLGLPPLPKSFWEKSMFEKPPDrEVVCHA 310
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 343 KAWRYYALPRTNFTYCPLNDEERFFNMFEAQSDLQYYRAASIQPTLLQEEPFPNFSDAIGKCFSMAASSPRFLRKLGMLR 422
Cdd:cd06461 311 SAWDFYNGDDFRIKMCTEVTMEDFLTVHHEMGHIQYYMAYKDQPVLFREGANPGFHEAIGDTIALSVSTPKHLKRLGLLD 390
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 423 DNKWKElPARLNRLYIQGLRVVFLLPVFYVLDRYRVEVLAGHIKADD-NEAYWRLTELYTGAAAPTKRTNEQFDVPAKLL 501
Cdd:cd06461 391 DNVDDE-EADINFLLKQALDKIAFLPFGYLLDKWRWDVFSGEIPPDEyNEAWWELREKYQGIVPPVPRSEEDFDPGAKYH 469
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153 502 MEVDDQYASNFLSIVLQFQLLKHFCTITGQfemgnpRKPLDMCDLSDQRGIGEILKRAMSLGSSVHYREVLKVLLGEPEI 581
Cdd:cd06461 470 IPANTPYIRYFLSTILQFQFHKALCKAAGH------TGPLHKCDIYGSKEAGKKLKKMLSLGSSKPWPDALEELTGEREL 543
                       570       580
                ....*....|....*....|
gi 28574153 582 SIDGLLTYFQPLQDWLQHQN 601
Cdd:cd06461 544 DASPLLEYFQPLYDWLKEEN 563
Peptidase_M2 pfam01401
Angiotensin-converting enzyme; Members of this family are dipeptidyl carboxydipeptidases ...
25-610 9.75e-99

Angiotensin-converting enzyme; Members of this family are dipeptidyl carboxydipeptidases (cleave carboxyl dipeptides) and most notably convert angiotensin I to angiotensin II. Many members of this family contain a tandem duplication of the 600 amino acid peptidase domain, both of these are catalytically active. Most members are secreted membrane bound ectoenzymes.


Pssm-ID: 460196  Cd Length: 581  Bit Score: 312.59  E-value: 9.75e-99
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153    25 RFLNETNQQLAVIYDQAVLAQLLNE--LRGPNDLvALLEIEVtddKLVKYVRTLTTRKAKFKRLGLGDSRQRRLLDKIPQ 102
Cdd:pfam01401   9 EFLEEYNREAEKVLNESTEASWNYNtnITDENAQ-KMLEASL---ELAAFTKETAQEAKQFDWSNFQDPDLKRQFKKLSV 84
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153   103 LGYEALSGRDLKLVYALASSMSDNYHNVKLCAYKQPGNCtLRLIPEVQSIVQGSRDLDEIEYYWFEWRSRTGLATRSQFV 182
Cdd:pfam01401  85 LGTAALPEDKLEELNTILSEMESIYSKAKVCLYDDPGPC-LSLEPDLTEIMATSRDYDELLWAWEGWRDAVGKPLRPLYE 163
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153   183 DFMDLYKKTAQLNGYPRAEDYWFRSLElkgQET-MNLLDRIMHGLRPLFLQFHAHVRGSLRKMHGEHLVPRNRPYPQHLa 261
Cdd:pfam01401 164 RYVELSNEAAKLNGYADTGAYWRSWYE---SDTfEEDLERLFQQLKPLYLQLHAYVRRKLREKYGPDVISLTGPIPAHL- 239
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153   262 evfIGNAFRRveaEW---YvDL--PSPEIGLANITQELHRRGLsTTQRVFWNVAEYFRALGFPQLENSLWTYAQ--KVSS 334
Cdd:pfam01401 240 ---LGNMWAQ---SWsniY-DLvvPFPDKPNIDVTDAMVAQGY-TAKKMFEEAEEFFTSLGLLPMPPEFWDKSMleKPTD 311
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153   335 DDDDRCWHKAWRYYAlpRTNF--TYCPLNDEERFFNMFEAQSDLQYYRAASIQPTLLQEEPFPNFSDAIGKCFSMAASSP 412
Cdd:pfam01401 312 GREVVCHASAWDFYN--GKDFriKMCTEVTMEDFFTVHHEMGHIQYYLQYKDQPVLFREGANPGFHEAVGDVLALSVSTP 389
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153   413 RFLRKLGMLrDNKWKELPARLNRLYIQGLRVVFLLPVFYVLDRYRVEVLAGHIKADD-NEAYWRLTELYTGAAAPTKRTN 491
Cdd:pfam01401 390 KHLKSIGLL-DDVVEDEESDINFLLKQALDKIAFLPFGYLIDKWRWGVFSGEIPPEDyNKRWWELRLKYQGICPPVPRTE 468
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 28574153   492 EQFDVPAKLLMEVDDQYASNFLSIVLQFQLLKHFCTITGQFemgnprKPLDMCDLSDQRGIGEILKRAMSLGSSVHYREV 571
Cdd:pfam01401 469 SDFDPGAKYHVPANVPYIRYFVSFILQFQFHKALCQAAGHT------GPLHKCDIYGSKEAGAKLKEMLKLGSSKPWPEA 542
                         570       580       590
                  ....*....|....*....|....*....|....*....
gi 28574153   572 LKVLLGEPEISIDGLLTYFQPLQDWLQHQNQENNLEVGW 610
Cdd:pfam01401 543 LEAITGQRKMDASALLEYFEPLIDWLKEQNERNGEIVGW 581
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH